Intellectual property (IP) is a key asset for life sciences companies, especially in the form of patents Valuation of these crucial assets requires a deep understanding of how the industry works and… read more…
The 2023 Global Innovation Index (GII) has been formally unveiled by the World Intellectual Property Organisation (WIPO) This latest GII assesses 132 nations, monitoring worldwide innovation… read more…
Over the past few months, recent decisions concerning the notion of plausibility and the ability to rely on evidence not provided at the time of filing have been released both at the European Patent… read more…
Mathys & Squire is delighted that Partners Sean Leach, Anna Gregson, Dani Kramer and Martin MacLean have all been identified in the 2023 edition of IAM Strategy 300: The World’s Leading IP… read more…
We are pleased to announce the appointment of a Partner and Head of Trade Marks Helen Cawley With over 20 years’ of experience in the trade mark field, both in-house and in private practice,… read more…
This decision of the European Patent Office (EPO) Boards of Appeal clarifies that the concept of ‘whole range sufficiency’ applies to all types of inventions, not just to fields of chemistry and… read more…
Data and commentary provided by Mathys & Squire has featured in an article by TechEU and Life Sciences Intellectual Property Review providing an update on the rise of patent applications… read more…
As of 1 May 2023, there has been a substantial change in the manner in which the compliance period for UK divisional patent applications is determined The compliance period defines the deadline… read more…
The UK Intellectual Property Office (IPO) has released a report outlining statistics regarding patents, trade marks, designs, and hearings for 2022 The data shows an increase in patent applications… read more…